By Joe Savarese
Here’s the crash course..
The Ebola Virus is part of the Filoviridae family, meaning it’s a helical single-stranded negative-sense RNA strand. (Remember a negative-stranded virus must carry with it a RNA-dependent RNA polymerase for infectivity).
Marburg virus is in the same class and is very similar to Ebola since both present as fatal hemorrhagic fevers. The Marburg virus has a natural reservoir in monkeys, while unknown in the Ebola virus, it is believed to be in bats. Most outbreaks of Ebola thus far have occurred in Sub-Saharan Africa such as Uganda and the Democratic Republic of the Congo.
Signs, Symptoms, and Diagnosis
The CDC has listed on their website symptoms of Ebola including fever, headache, muscle pain, weakness, diarrhea, vomiting, abdominal pain, and unexplained bruising and bleeding. Symptoms may appear from 2 to 21 days after exposure. After flu-like symptoms appear, infection continues to other organs such as the brain, kidney, and intestines leading to third spacing, shock, and hemorrhagic findings.
In general, transmission is by similar routes as HIV – bodily fluids, needle sharing, and infected animals. However, there has been no evidence of sexual transmission of Ebola even when RNA levels are detected in the semen (cdc.gov). The virus is not transmitted through air or water. Obviously, due to lack of patients, studies have been limited in this field. Click here for more information on transmission from the CDC.
Ebola is detectable through measuring RNA blood levels, which are near threshold or low when symptoms and fever first develop making it difficult and unreliable to have a positive test before fever. Symptoms of Ebola are also very nonspecific, which makes early diagnosis difficult.
It should be no surprise that for testing, ELISA method and PCR are used. (Couldn’t hurt to brush up on these methods here and here.
Treatment
Supportive care. Currently, several companies are working to develop a vaccine. One product called ZMapp that may enter Phase 1 drug testing soon uses monoclonal antibodies for treatment (it was already used on two Americans). Serum from survivors might be used because of the formed antibodies that might be key to fight the infection.
Prophylaxis
Isolation from infected individuals. Interestingly enough, about a year ago, some studies showed in mice that Selective Estrogen Receptor Modulators (SERMs) like clomiphene may prevent the viral fusion of the Ebola virus. (Here’s the article for your ID pimp sessions.)
Practice Case:
A 42-year-old Ugandan patient with a 4-day history of fever, maculopapular rash, elevated liver enzymes, and thrombocytopenia is found to have positive serological studies indicating Ebola infection. After analysis of the RNA genome, the virus is found to have a point mutation when compared to another patient that was isolated in another region of Uganda. What genetic phenomenon mostly likely occurred that may lead to a future epidemic?
a. Genetic shift
b. Genetic drift
c. Reassortment
d. Phenotypic mixing
e. Specialized Transduction
Put your answer in the comment section!